女性供者男性受者异基因造血干细胞移植前Y染色体缺失
研究评估2010至2019年日本成人男性接受女性供者异基因造血干细胞移植的病例,比较Y染色体缺失组155例与无缺失组4149例。多因素分析显示Y染色体缺失与较差的总生存(HR 1.24,95%CI 1.00-1.53,P=.049)及复发风险增加(HR 1.40,95%CI 1.08-1.80,P=.0098)显著相关,非复发死亡率无显著差异(HR 1.08,95%CI 0.769-1.51,P=.67)。在男性供者男性受者队列中,Y染色体缺失与任何临床结局均无显著关联。
要点
- 女性供者男性受者移植中,Y染色体缺失与较差总生存及复发风险增加显著相关。
- Y染色体缺失组与非缺失组非复发死亡率无显著差异。
- 男性供者男性受者移植中,Y染色体缺失与临床结局无显著关联。
核心结论
- 在女性供者男性受者异基因造血干细胞移植中,Y染色体缺失与较差的总生存和增加的复发风险显著相关,可能与H-Y抗原缺失导致移植物抗白血病效应减弱有关。
- 在男性供者男性受者移植中,Y染色体缺失与任何临床结局均无显著关联。
研究设计与样本
- 研究纳入2010年至2019年在日本接受异基因造血干细胞移植的成人男性患者,女性供者男性受者队列中Y染色体缺失组155例、无Y染色体缺失组4149例。
主要发现
- 女性供者男性受者移植中,Y染色体缺失与较差的总生存显著相关(HR 1.24;95%CI 1.00-1.53;P=.049)。
- 女性供者男性受者移植中,Y染色体缺失与复发风险增加显著相关(HR 1.40;95%CI 1.08-1.80;P=.0098)。
- 女性供者男性受者移植中,Y染色体缺失组与非缺失组的非复发死亡率无显著差异(HR 1.08;95%CI 0.769-1.51;P=.67)。
- 男性供者男性受者移植队列中,Y染色体缺失与任何临床结局均无显著关联。
临床怎么用
- 作者认为,女性供者男性受者移植中Y染色体缺失导致H-Y抗原缺失,可能减弱移植物抗白血病效应,因此可能需要在移植后采取额外策略预防疾病复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The graft-versus-leukemia (GVL) effect is one of the curative mechanisms of allogeneic hematopoietic stem cell transplantation (allo-HCT). H-Y antigens, which are encoded by Y chromosome, are important targets of the GVL effect. Thus, deletion of the Y chromosome (del[Y]) might cause the GVL effect to deteriorate in a transplantation involving a female donor and male recipient, although the clinical significance of the del(Y) group remains to be elucidated. In this study, we evaluated adult male patients who underwent allo-HCT between 2010 and 2019 in Japan. There were 155 cases in the del(Y) group and 4149 cases without del(Y) who underwent female-to-male allo-HCT. Del(Y) was significantly associated with inferior overall survival (hazard ratio [HR], 1.24; 95% confidence interval [CI], 1.00-1.53; P = .049) and an increased risk of relapse (HR, 1.40; 95% CI, 1.08-1.80; P = .0098) in multivariate analyses. There was no significant difference in nonrelapse mortality between recipients with and without del(Y) (HR, 1.08; 95% CI, 0.769-1.51; P = .67). In contrast, del(Y) was not significantly associated with any clinical outcomes in the cohort of male-to-male allo-HCT. A higher incidence of relapse might have been caused by attenuation of the GVL effect resulting from a lack of H-Y antigens. Because a GVL effect resulting from sex mismatch may not be expected in men with del(Y) who undergo allo-HCT with a female donor, additional post-allo-HCT strategies might be required to prevent disease relapse.
引用
- Tamaki M, Kameda K, Kimura SI, et al. Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors. Blood Adv. 2022. PMID: 35108728. doi:10.1182/bloodadvances.2021006456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。